TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18827019

Group type: EXPERIMENTAL
Intervention: 5 mg/day testosterone (T)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: 75 mg/day dehydroepiandrosterone (DHEA)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: 50 mg/day dehydroepiandrosterone (DHEA)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Young individuals (18-31 years)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Elderly women
Number of subjects: 206
Study: 16821176

Group type: EXPERIMENTAL
Intervention: Multidisciplinary in-patient treatment program
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Intense activating group treatment (subgroup analysis)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 307
Study: 12719069

Group type: EXPERIMENTAL
Intervention: Spherical contact lenses (SPH)
Number of subjects: 15

Group type: COMPARATOR
Intervention: With-the-rule astigmatism (WTR) contact lenses
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Against-the-rule astigmatism (ATR) contact lenses
Number of subjects: 15
Study: 10695822

Group type: COMPARATOR
Intervention: 16 oz whole cow's milk (WCM) daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Soy formula daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Therapeutic oral iron treatment
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Correction of IDA
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Excessive WCM intake (30 oz/day or more)
Number of subjects: 24
Study: 9137133

Group type: EXPERIMENTAL
Intervention: Pentagastrin
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 7870929

Group type: COMPARATOR
Intervention: DHEAS/CRT ratio in elderly controls (aged > 60)
Number of subjects: 74

Group type: COMPARATOR
Intervention: DHEAS/CRT ratio in female AD patients
Number of subjects: 74

Group type: COMPARATOR
Intervention: CRT plasma levels in female AD patients
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: CRT plasma levels between female and male AD patients
Number of subjects: 74

Group type: COMPARATOR
Intervention: DHEAS/CRT ratios in AD patients
Number of subjects: 74
Study: 3002720

Group type: EXPERIMENTAL
Intervention: Neo Sampoon
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Ortho Vaginal Tablets (OVT)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Emko Vaginal Tablets (EVT)
Number of subjects: 300
Study: 28816373

Group type: EXPERIMENTAL
Intervention: 80 mL simethicone/Pronase solution plus 10 mL lidocaine hydrochloride mucilage (SP/LHM)
Number of subjects: 610

Group type: COMPARATOR
Intervention: 10 mL lidocaine hydrochloride mucilage (LHM)
Number of subjects: 610
Study: 27655503

Group type: EXPERIMENTAL
Intervention: Gastrointestinal decompression with dynamic and profound adjustment of the gastric tube and abdomen movement (Observation group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Routine continuous gastrointestinal decompression (Control group)
Number of subjects: 36
Study: 23790120

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 50
Study: 21174129

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT) sleep intervention composed of stimulus control, modified sleep restriction (MSR), relaxation therapy (RT), and sleep hygiene counseling
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT) sleep intervention
Number of subjects: 113
Study: 20600604

Group type: EXPERIMENTAL
Intervention: Real putting condition
Number of subjects: 10

Group type: COMPARATOR
Intervention: Virtual putting condition
Number of subjects: 10
Study: 18349431

Group type: EXPERIMENTAL
Intervention: Subjects randomized to estimate the probability of treatment success after learning their diagnosis (after group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subjects randomized to estimate the probability of treatment success before learning their diagnosis (before group)
Number of subjects: 0
Study: 15849646

Group type: EXPERIMENTAL
Intervention: ESWT without local anesthesia (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ESWT with local anesthesia (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ESWT with local anesthesia (Group C)
Number of subjects: 60
Study: 12823159

Group type: EXPERIMENTAL
Intervention: 150 mg ranitidine at bedtime
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 10571438

Group type: EXPERIMENTAL
Intervention: RRV-TV (4 x 10(4) pfu/dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: RRV-TV (4 x 10(5) pfu/dose)
Number of subjects: 0
Study: 8766483

Group type: EXPERIMENTAL
Intervention: Fetal pulse oximetry (PO)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no fetal pulse oximetry)
Number of subjects: 63
Study: 1927942

Group type: EXPERIMENTAL
Intervention: Anistreplase (30 U/5 min)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Streptokinase (1.5 million IU/1 hour)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Early patency (both treatments)
Number of subjects: 370
Study: 6129609

Group type: EXPERIMENTAL
Intervention: Combined salbutamol-dexamethasone treatment
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: COMPARATOR
Intervention: Salbutamol alone
Number of subjects: 32

Group type: COMPARATOR
Intervention: Dexamethasone alone
Number of subjects: 32
Study: 31327317

Group type: COMPARATOR
Intervention: No-ICAS group (control)
Number of subjects: 709

Group type: EXPERIMENTAL
Intervention: Severe-ICAS
Number of subjects: 709

Group type: EXPERIMENTAL
Intervention: Mild-ICAS
Number of subjects: 709
Study: 27587605

Group type: EXPERIMENTAL
Intervention: MCO AA
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: MCO BB
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: MCO CC
Number of subjects: 39

Group type: COMPARATOR
Intervention: High-flux HD
Number of subjects: 39

Group type: COMPARATOR
Intervention: HDF
Number of subjects: 39
Study: 26273724

Group type: EXPERIMENTAL
Intervention: Autobiographical retrieval
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 25145581

Group type: EXPERIMENTAL
Intervention: Crushing with intrinsic stripping (Group 2, n = 27)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Crushing (Group 1, n = 28)
Number of subjects: 42
Study: 22958869

Group type: EXPERIMENTAL
Intervention: Abstaining from smoking for 24h
Number of subjects: 275

Group type: COMPARATOR
Intervention: Smoking as usual
Number of subjects: 275
Study: 18270526

Group type: EXPERIMENTAL
Intervention: Food items enriched with mineral nutrients and 1.25, 2.5, and 5.0 g per day of plant sterols during the first, second, and third 5-week periods, respectively
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Food items enriched with mineral nutrients and plant sterols
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo group receiving similar food items without plant sterols
Number of subjects: 71
Study: 17441345

Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 40
Study: 15974216

Group type: EXPERIMENTAL
Intervention: Colgate Dental Gum (CDG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colgate Dental Gum (CDG) plus Colgate Winterfresh Gel (CWG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoride dentifrices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Colgate Winterfresh Gel (CWG)
Number of subjects: 0
Study: 12709609

Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy (ELC)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy (DLC)
Number of subjects: 169
Study: 10478139

Group type: EXPERIMENTAL
Intervention: Novel flow cytometric approach for TdT expression detection
Number of subjects: 68

Group type: COMPARATOR
Intervention: Parallel immunoperoxidase staining and microscopic evaluation
Number of subjects: 68
Study: 8609242

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg, single oral dose)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1960828

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy plus the best medical care (n = 91)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Best medical care alone (n = 98)
Number of subjects: 189
Study: 7274266

Group type: EXPERIMENTAL
Intervention: Quinidine arabogalactane-sulfate (QAGS)
Number of subjects: 207

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 207
Study: 31010126

Group type: EXPERIMENTAL
Intervention: TMPRSS6 SNP rs855791
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: TMPRSS6 SNP rs4820268
Number of subjects: 121
Study: 29098257

Group type: EXPERIMENTAL
Intervention: Oral implantation
Number of subjects: 94

Group type: COMPARATOR
Intervention: Conventional restoration
Number of subjects: 94
Study: 26163028

Group type: EXPERIMENTAL
Intervention: Probiotic VSL#3 (10 billion cfu) for 30 days
Number of subjects: 1340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1340
Study: 23602881

Group type: EXPERIMENTAL
Intervention: Muscle strength exercises (SE)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Aerobic exercises (AE)
Number of subjects: 451
Study: 20632222

Group type: EXPERIMENTAL
Intervention: Computer-based decision aid (Decision-Aid Group, n = 60)
Number of subjects: 121
Study: 19589139

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 318

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 318

Group type: COMPARATOR
Intervention: Acute stress patients
Number of subjects: 318
Study: 17361532

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) recipes formulated by Shen‐replenishing herbs or acupuncture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined therapy of Shen‐replenishing recipe and acupuncture with hormone or ovulation promoting drugs of Western medicine
Number of subjects: 0
Study: 12919759

Group type: EXPERIMENTAL
Intervention: Needleless connectors
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard caps
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Isopropyl alcohol
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Chlorhexidine/alcohol
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Povidone-iodine
Number of subjects: 77
Study: 11314640

Group type: EXPERIMENTAL
Intervention: Training plus accountability (experimental group I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Training without accountability (experimental group II)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 0
Study: 9396637

Group type: EXPERIMENTAL
Intervention: Low-molecular weight heparins (LMWHs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct thrombin inhibitors
Number of subjects: 0
Study: 8418711

Group type: EXPERIMENTAL
Intervention: Preinduction Acute Hemodilution (AH)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Postinduction Acute Hemodilution (AH)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (Homologous Blood Transfusion)
Number of subjects: 40
Study: 2948987

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 60
Study: 30113915

Group type: EXPERIMENTAL
Intervention: Slow Accentuated Eccentric Loading (AEL)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fast Accentuated Eccentric Loading (AEL)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Fast Traditional Resistance Training (TRT)
Number of subjects: 14
Study: 26807536

Group type: EXPERIMENTAL
Intervention: BPI (Brief Pain Inventory)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: PEG (3-item PEG scale)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: SF-36 Bodily Pain
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: PROMIS Pain Interference short forms
Number of subjects: 250

Group type: COMPARATOR
Intervention: BPI, PEG, SF-36 Bodily Pain, PROMIS Pain Interference
Number of subjects: 250
Study: 23904206

Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo-electrical stimulation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Conventional rehabilitation (Control)
Number of subjects: 73
Study: 22378728

Group type: EXPERIMENTAL
Intervention: Intervention group (specific intervention details not provided)
Number of subjects: 230
Study: 20467009

Group type: EXPERIMENTAL
Intervention: Tertile III caloric intake (>64.6%)
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Increasing caloric intake
Number of subjects: 523

Group type: COMPARATOR
Intervention: Tertile I caloric intake (<33.4%)
Number of subjects: 523
Study: 18158630

Group type: EXPERIMENTAL
Intervention: Early feeding (clear fluids and solid food within 8 h of surgery)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Traditionally fed (clear fluids 8-12 h after surgery)
Number of subjects: 179
Study: 15962873

Group type: EXPERIMENTAL
Intervention: Easyhaler
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Diskus
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Turbuhaler
Number of subjects: 326
Study: 12667600

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich juice A (236 mg polyphenols, cyanidin glycosides)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich juice B (226 mg polyphenols, epigallocatechin gallate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no juice)
Number of subjects: 0
Study: 11194788

Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intensive medical management including pulmonary rehabilitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical techniques (bilateral by MS or VATS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selection criteria for optimal response
Number of subjects: 0

Group type: COMPARATOR
Intervention: Criteria to determine prohibitive surgical risk
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-term cost effectiveness
Number of subjects: 0
Study: 8795441

Group type: EXPERIMENTAL
Intervention: gamma‐L‐glutamyl‐L‐3,4‐dihydroxyphenylalanine (gludopa)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: gamma‐L‐glutamyl‐5‐hydroxy‐L‐tryptophan
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Simultaneous infusion of gludopa and gamma‐L‐glutamyl‐5‐hydroxy‐L‐tryptophan
Number of subjects: 8
Study: 1531218

Group type: EXPERIMENTAL
Intervention: etanidazole combined with radiotherapy (ETA)
Number of subjects: 374

Group type: COMPARATOR
Intervention: radiotherapy alone (RT)
Number of subjects: 374
Study: 6372934

Group type: EXPERIMENTAL
Intervention: Cholecystokinin (CCK) infusion (1 Ivy Dog Unit/kg over 5 min)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Normal saline (placebo) infusion
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Repeat CCK infusion postoperatively
Number of subjects: 41
Study: 29699509

Group type: EXPERIMENTAL
Intervention: Short-term fasting (STF) during chemotherapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normocaloric diet (non-fasted) during chemotherapy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Short-term fasting (STF)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normocaloric diet (non-fasted)
Number of subjects: 34
Study: 29471772

Group type: EXPERIMENTAL
Intervention: Psycho-education group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (standardized educational materials)
Number of subjects: 64
Study: 24875026

Group type: EXPERIMENTAL
Intervention: Patellar eversion
Number of subjects: 120

Group type: COMPARATOR
Intervention: Patellar lateral retraction
Number of subjects: 120
Study: 22031510

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training at 60-80% of maximal oxygen consumption (VO2max) for 10 weeks, three 1-hour sessions per week.
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 28
Study: 20706626

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307
Study: 18519174

Group type: EXPERIMENTAL
Intervention: Risedronate (RIS), 35 mg once weekly
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 87
Study: 15960638

Group type: EXPERIMENTAL
Intervention: 0.5 mg.kg(‐1) oral midazolam
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 0.25 mg.kg(‐1) oral midazolam with 2.5 mg.kg(‐1) oral ketamine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (midazolam alone)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (midazolam alone and midazolam with ketamine)
Number of subjects: 100
Study: 12438486

Group type: EXPERIMENTAL
Intervention: Regular change of ventricular catheter every five days
Number of subjects: 103

Group type: COMPARATOR
Intervention: No change unless clinically indicated
Number of subjects: 103
Study: 10622653

Group type: COMPARATOR
Intervention: BUP 0.5% with no EPI
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: BUP 0.5% with EPI 1:300,000
Number of subjects: 40

Group type: COMPARATOR
Intervention: BUP 0.25% with no EPI
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: BUP 0.25% with EPI 1:300,000
Number of subjects: 40
Study: 7485479

Group type: EXPERIMENTAL
Intervention: L-[3,4-3H]glutamine infusion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Natural L-glutamine infusion
Number of subjects: 6
Study: 1826739

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.15 mg/kg IV every 4 hours for three doses
Number of subjects: 307

Group type: COMPARATOR
Intervention: Metoclopramide 2 mg/kg IV every 2 hours for three doses, then every 3 hours for three additional doses
Number of subjects: 307
Study: 6789798

Group type: EXPERIMENTAL
Intervention: Hanks' transport media
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Stuart's transport media
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Leibovitz‐Emory (LEM) transport media
Number of subjects: 200
Study: 31593559

Group type: EXPERIMENTAL
Intervention: 25g of phenols-rich extra virgin olive oil (p-EVOO)
Number of subjects: 22
Study: 26210962

Group type: EXPERIMENTAL
Intervention: Ropivacaine (2%) with adrenaline (0.01%)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ropivacaine (2%) without adrenaline
Number of subjects: 50
Study: 25616192

Group type: EXPERIMENTAL
Intervention: Feeding Dynamic Intervention (FDI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list Control Group (WLC)
Number of subjects: 0
Study: 23912950

Group type: EXPERIMENTAL
Intervention: Alendronate plus vitamin D3 5,600 IU (ALN/D)
Number of subjects: 391

Group type: COMPARATOR
Intervention: Standard care (SC) with alendronate (SC/ALN)
Number of subjects: 391
Study: 22887722

Group type: EXPERIMENTAL
Intervention: Women with heart failure with preserved ejection fraction
Number of subjects: 4128

Group type: COMPARATOR
Intervention: Men with heart failure with preserved ejection fraction
Number of subjects: 4128
Study: 19406691

Group type: EXPERIMENTAL
Intervention: Body-weight supported treadmill training (BWSTT)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Head-up tilt training (HUTT)
Number of subjects: 7
Study: 17425814

Group type: EXPERIMENTAL
Intervention: Entropy group (propofol induction based on entropy reading)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (recommended induction dose of propofol)
Number of subjects: 72
Study: 15611507

Group type: EXPERIMENTAL
Intervention: myeloablative radiochemotherapy followed by ASCT
Number of subjects: 440

Group type: COMPARATOR
Intervention: interferon alfa (IFN-alpha) maintenance
Number of subjects: 440
Study: 11227969

Group type: EXPERIMENTAL
Intervention: Heparin (100 IU/kg, intravenously) administered immediately after introduction of the femoral venous sheaths (group I)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Heparin administered after the initial electrophysiological study (groups II and III)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline irrigation of all femoral sheaths (group II)
Number of subjects: 30
Study: 11134095

Group type: EXPERIMENTAL
Intervention: High calcium intake (47.4 mmol/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low calcium intake (21.2 mmol/day)
Number of subjects: 10
Study: 9345833

Group type: EXPERIMENTAL
Intervention: Warfarin therapy
Number of subjects: 50
Study: 8186380

Group type: COMPARATOR
Intervention: Hyoscine N-butyl bromide (20 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Propinoxate (5 mg) plus diazepam
Number of subjects: 46
Study: 2951570

Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate (1% solution)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Tetracycline (solution)
Number of subjects: 34
Study: 30145122

Group type: EXPERIMENTAL
Intervention: Preoperative visitation by surgical technologist (intervention group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine preoperative care by nurses (control group)
Number of subjects: 70
Study: 29370257

Group type: EXPERIMENTAL
Intervention: Ear endoscopy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Ear microscopy
Number of subjects: 32
Study: 27732647

Group type: EXPERIMENTAL
Intervention: Grooming
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Food competition
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Food anticipation
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Waving a plastic bag
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control phases
Number of subjects: 16
Study: 24256028

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 306

Group type: COMPARATOR
Intervention: Control (routine care only)
Number of subjects: 306
Study: 21941363

Group type: EXPERIMENTAL
Intervention: Face-down posture
Number of subjects: 30

Group type: COMPARATOR
Intervention: No posture
Number of subjects: 30
Study: 20234000

Group type: EXPERIMENTAL
Intervention: Web administration of the Youth Risk Behavior Survey (YRBS)
Number of subjects: 5227

Group type: COMPARATOR
Intervention: Paper-and-pencil administration of the Youth Risk Behavior Survey (YRBS)
Number of subjects: 5227